Abiopharma

New Form 3 - ENANTA PHARMACEUTICALS INC Filed: 2025-09-08 AccNo: 0001062993-25-015414 Size: 16 KB

New Form SCHEDULE 13G - vTv Therapeutics Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026895 Size: 26 KB

New Form SCHEDULE 13D/A - Mineralys Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001415889-25-023895 Size: 19 KB

RA CAPITAL MANAGEMENT, L.P. 🟢 acquired 1.2M shares of Mineralys Therapeutics, Inc. (MLYS) at $25.50 ($30.0M) Transaction Date: Sep 04, 2025 | Filing ID: 023893

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

New Form 144 - Warby Parker Inc. Filed: 2025-09-08 AccNo: 0001958244-25-004311 Size: 5 KB

Sable Kyle 🟡 adjusted position in 40.0K shares (1 derivative) of Perimeter Solutions, Inc. (PRM) at $22.05 ($1.2M) Transaction Date: Sep 05, 2025 | Filing ID: 000113

Emery Jeffrey 🟡 adjusted position in 300.0K shares (1 derivative) of Perimeter Solutions, Inc. (PRM) at $22.28 ($11.7M) Transaction Date: Sep 04, 2025 | Filing ID: 000112

Director Mun-Gavin David C. 🟢 acquired 31.2K shares (1 derivative) of GT Biopharma, Inc. (GTBP) at $1.33 Transaction Date: Sep 04, 2025 | Filing ID: 026893

Director Breen Michael Martin 🟢 acquired 300.0K shares (3 derivative) of GT Biopharma, Inc. (GTBP) at $1.33 Transaction Date: Sep 04, 2025 | Filing ID: 026890

New Form SCHEDULE 13G - Kezar Life Sciences, Inc. Filed: 2025-09-08 AccNo: 0000935836-25-000592 Size: 17 KB

New Form SCHEDULE 13G - vTv Therapeutics Inc. Filed: 2025-09-08 AccNo: 0002005369-25-000046 Size: 27 KB

SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025

Director Ceesay Abraham 🔴 sold 2.4K shares of Pacira BioSciences, Inc. (PCRX) at $27.19 Transaction Date: Sep 04, 2025 | Filing ID: 000109

New Form SCHEDULE 13G - Crinetics Pharmaceuticals, Inc. Filed: 2025-09-08 AccNo: 0000908834-25-000292 Size: 53 KB